![[AIDS 2026] Infectious Disease Special Edition: Long-acting Cabenuva shows comparable real](https://healthylife7.com/wp-content/uploads/2026/08/1674900.jpg "[AIDS 2026] Infectious Disease Special Edition: Long-acting Cabenuva shows comparable real")
[AIDS 2026] Infectious Disease Special Edition: Long-acting Cabenuva shows comparable real-world effectiveness to daily Biktarvy
- It Starts and Ends with Us: Community at the Centre of Clinical Studies
- Donate
- Get involved
- Subscribe
[AIDS 2026] Infectious Disease Special Edition: Long-acting Cabenuva shows comparable real-world effectiveness to daily Biktarvy
Back to the “HIV and Co-Infections News” list
- HIV Treatment
August 2, 2026
Tags:
- AIDS 2026
- Long-Acting Antiretrovirals
Infectious Disease Special Edition news story
Switching to long-acting injectable cabotegravir-rilpivirine (CAB/RPV; Cabenuva, ViiV Healthcare) every two months maintained virologic suppression as effectively as switching to daily oral bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF; Biktarvy, Gilead) in a large real-world U.S. cohort, according to findings presented at AIDS 2026
The analysis used electronic health record data from the OPERA cohort, which included 101 clinics and represented approximately 14% of people living with HIV in the United States. Investigators evaluated treatment-experienced adults who were virologically suppressed before switching for the first time to either regimen between February 2022 and March 2025
Read the full news story here
/free registration is required/
View allInfectious Disease Special Editionreports from AIDS 2026
Source :Infectious Disease Special Edition
Related HIV and Co-Infections News
See all related HIV and Co-Infections News
- August 2, 2026
[AIDS 2026] aidsmap: Alternative first-line HIV regimen limits excess weight gain
- July 30, 2026
[AIDS 2026] aidsmap: Once-weekly islatravir/lenacapavir combination pill maintains HIV viral suppression
- July 30, 2026
[AIDS 2026] aidsmap: Islatravir plus ulonivirine shows promise for weekly oral HIV treatment
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
- Become a member
- Support us
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your inbox
This website uses cookies. Some cookies are necessary for the proper functioning of the website and can not be refused if you want to visit this website. Other cookies are used for social network sharing, video playback and analysis purposes. You can refuse them if you want. Read our cookie policy
